Athersys Inc (NASDAQ:ATHX)

0.254
BATS BZX Real-Time Price
As of 2:40pm ET
 -0.0013 / -0.51%
Today’s Change
0.17
Today|||52-Week Range
1.81
-71.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$68.1M

Company Description

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

Contact Information

Athersys, Inc.
3201 Carnegie Avenue
Cleveland Ohio 44115-2634
P:(216) 431-9900
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Daniel A. CamardoCEO, Co-CFO, Secretary, Director & CAO
Maia A. HansenChief Operating Officer
Kasey RosadoChief Financial Officer
Rakesh RamachandranHead-Information Technology & Communications
Eric JenkinsVP-Clinical Development & Medical Affairs